Novo Nordisk | Capitaux D'Emprunt



Loan Capital Changement Date
ANI Pharmaceuticals USD 608.35M 3.28M 2025-06
Aurora Cannabis CAD 41.68M 542K 2024-12
Bausch Health Companies USD 20.86B 369M 2025-06
Bristol-Myers Squibb USD 44.47B 1.69B 2025-06
Canopy Growth CAD 467.93M 34.44M 2024-12
Corcept Therapeutics USD 0 0 2025-03
Drreddys Laboratories INR 7.58B 218M 2024-12
Eli Lilly USD 34.18B 319.4M 2025-06
GlaxoSmithKline GBP 15.3B 1.17B 2025-06
Merck USD 33.97B 484M 2025-06
Novartis USD 24.06B 2.4B 2025-06
Novo Nordisk 87.3B 9.01B 2025-06
Novo Nordisk DKK 96.31B 44.86B 2025-03
Pacira USD 378.1M 3.2M 2025-06
Perrigo USD 3.62B 24.2M 2025-06
Prestige Brands USD 1.01B 256K 2025-06
Sanofi 13.2B 211M 2025-06
Supernus Pharmaceuticals USD 0 0 2024-12
Zoetis USD 5.23B 4M 2025-06


Novo Nordisk Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.